Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT02975908 Recruiting - Clinical trials for Acute Respiratory Distress Syndrome

A Realworld Study of Acute Respiratory Distress Syndrome in China

CHARDSnet
Start date: August 2015
Phase: N/A
Study type: Observational

ARDS is a critical respiratory disease caused by endogenous and exogenous factors. The mortality of ARDS varies from 30 to 70%. In 2012, a new international diagnostic criterion has been put forward. Yet, its feasibility, reliability and validity need to be tested. Meanwhile, the correlation of different severity and prognosis remains unclear. As so far, the epidemiological information about ARDS in China is lacking. Investigators plan to conduct a multi-center observational study(real-life study) to investigate the risk factors, morbidity, management and prognosis of ARDS in China, in order to facilitate standardization of diagnosis and management of ARDS and provide basic data and idea for further clinical intervention studies.

NCT ID: NCT02967822 Recruiting - Clinical trials for Mayer Rokitansky Kuster Hauser Syndrome

Molecular Genetic Study of Mayer-Rokitansky-Kuster-Hauser Syndrome

MRKH
Start date: May 2016
Phase:
Study type: Observational

In order to understand the molecular mechanisms leading to Mayer-Rokitansky-Kuster-Hauser syndrome (MRKH), the research team has to identify molecular bases of this anomaly. Toward this goal, the research team would like to include in the study patients with MRKH syndrome, as well as their healthy relatives, in order to perform genetic analyses, especially whole exome sequencing. This study has been set up in order to collect biological samples from patients with MRKH and their relatives.

NCT ID: NCT02964533 Recruiting - Clinical trials for Chronic Fatigue Syndrome

Thunder-Fire Moxibustion Therapy for Chronic Fatigue Syndrome on Shenque Acupoint: a Randomized Controlled Trial

Start date: November 2016
Phase: N/A
Study type: Interventional

Chronic fatigue syndrome is a group of syndrome and is prevalent in adult. Thunder-fire moxibustion is a commentary therapy belonged to acupuncture therapy. To evaluate the effect and safety of thunder-fire moxibustion therapy for chronic fatigue syndrome, we apply a randomized controlled trial by recruiting chronic fatigue syndrome patient as subject, applying thunder-fire moxibustion on shenque acupoint contrasted to common moxa-stick moxibustion, taking fatigue rating scale score, the content of CD3+、CD4+、CD8+、CD4+/CD8+ as evaluation indexes. The treatment time is 20-30 minutes per session, 3-4 times a week, there are totally 15 sessions.

NCT ID: NCT02958579 Recruiting - Clinical trials for Metabolic Syndrome X

a Population Based Study on Metabolic Syndrome Complications, and Mortality

MetSCoM
Start date: January 2005
Phase: N/A
Study type: Observational

Metabolic syndrome (MetS) is recognized as clustering of a number of components including hypertension, hypertriglyceridemia, low serum high-density lipoprotein cholesterol (HDL-C), impaired glucose metabolism (IGM), and abdominal obesity. It has been tightly linked to thrombotic vascular events including coronary heart disease (CHD). Worldwide prevalence of MetS is on the rise. People living in Iran, a country located in the Middle-East region, have distinct behavioral, environmental and social exposures which certainly affect the prevalence and incidence of metabolic syndrome and its comorbidities.We hypothesized that these factors may affect the course of metabolic syndrome and the burden that it imposes to the community. The purposes of MetSCoM are as follows; 1. To find the incidence of T2D, microvascular complications of T2D (diabetic retinopathy, diabetic neuropathy and diabetic kidney disease), CVD, and mortality rate of subjects metabolic syndrome. 2. To find the association of baseline, mean value during follow up visits and visit to visit variability in anthropometric variables and several metabolic laboratory variables with metabolic syndrome and its complications. 3. To find the effect of behavioral variables and environmental exposures on the course of metabolic syndrome. 4. To identify the best anthropometric, laboratory, life-style and environmental predictors of CVD and mortality rate in subjects with metabolic syndrome. 5. To estimate the economic burden of metabolic syndrome and its related

NCT ID: NCT02958462 Recruiting - Clinical trials for Hematologic Neoplasms

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

Start date: January 16, 2017
Phase: N/A
Study type: Interventional

This clinical trial tests next generation sequencing (NGS) for the detection of precursor features of pre-myeloid cancers and bone marrow failure syndromes. NGS is a procedure that looks at relevant cancer associated genes and what they do. Finding genetic markers for pre-malignant conditions may help identify patients who are at risk of pre-myeloid cancers and bone marrow failure syndromes and lead to earlier intervention.

NCT ID: NCT02957175 Recruiting - Clinical trials for Systemic Inflammatory Response Syndrome

Immunophenotyping of Patients With Postoperative SIRS

Start date: November 2016
Phase:
Study type: Observational

The purpose of this study is to develop an immune-phenotype based prediction of postoperative SIRS in patients undergoing open heart surgery.

NCT ID: NCT02953171 Recruiting - Clinical trials for Irritable Bowel Syndrome

Probiotics in the Treatment of Irritable Bowel Syndrome

Start date: September 2016
Phase: N/A
Study type: Interventional

The aim of the present study is to assess the efficacy of two different probiotic products, lacto-fermented sauerkraut and the supplement Mutaflor, in the treatment of irritable bowel syndrome.

NCT ID: NCT02940366 Recruiting - Metabolic Syndrome Clinical Trials

Effect of High-dose Pitavastatin on Glucose Control in Patients With Metabolic Syndrome

Start date: December 1, 2016
Phase: Phase 4
Study type: Interventional

This purpose of this study is to evaluate effect of high-dose Pitavastatin on glucose control in patients with metabolic syndrome.

NCT ID: NCT02928991 Recruiting - Clinical trials for Bone Marrow Failure Syndromes

Fludarabine Based RIC for Bone Marrow Failure Syndromes

Start date: April 2015
Phase: Early Phase 1
Study type: Interventional

This is a pilot study to determine whether fludarabine-based reduced intensity conditioning (RIC) regimens facilitate successful donor engraftment of patients with acquired aplastic anemia (AA) and Inherited bone marrow failure (iBMF) syndromes undergoing Matched related donor bone marrow transplant (MRD-BMT).

NCT ID: NCT02909920 Recruiting - Clinical trials for Shoulder Impingement Syndrome

Effectiveness of Telerehabilitation Program in Subacromial Syndrome (Telerehab Sis)

telerehab
Start date: September 2016
Phase: N/A
Study type: Interventional

Shoulder pain is a common and high prevalence in the general population. Subacromial Syndrome (Shoulder Impingement Syndrome (SIS)) is the most frequent cause. SIS patients suffering pain, muscle weakness and loss of movement in the affected joint. Initial treatment of the SIS is predominantly conservative. Surgical option has high success rates and is often used when conservative strategy fails. Traditional Physiotherapy and Postoperative exercises is needed to the recovery of joint range, muscle strength, stability and functionality. This Research evaluates the feasibility and effectiveness of a telerehabilitatión Program in SIS after surgery compared with traditional therapy.